Menu

866-342-1929

Chat Now!

Recent Posts

Late last month – on Tuesday, October 21 st – Johnson & Johnson’s Janssen unit announced a recall of the popular blood-thinner medication Xarelto (rivaroxaban). According to officials from Janssen, 13,500 bottles of Xarelto are being recalled after microbial contamination was found in a sample. The U.S. Food and Drug Keep Reading
Pharmaceutical Injuries
In the past several months, concerns over the risks and safety of Xarelto – a popular prescription blood thinner – have been on the rise. In many cases, patients who took Xarelto have reported incidents of severe and uncontrollable bleeding, some serious enough to require hospitalization. A number of injuries Keep Reading
Pharmaceutical Injuries
A recent study conducted by a team of researchers at the University of Hawaii Cancer center is breaking new ground in the scientific understanding of mesothelioma. According to the researchers, mesothelioma may be caused by multiple cell mutations rather than a mutation in a single cell – which is the Keep Reading
Mesothelioma
Earlier this month, the U.S. Judicial Panel on Multidistrict Litigation announced the consolidation of federal Xarelto lawsuits in the United States District Court for the Eastern District of Louisiana. The announcement, made on December 12, is considered a turning point in nationwide litigation involving the popular blood-thinner, which has been Keep Reading
Pharmaceutical Injuries
Swedish researchers from Umea University’s Department of Health and Clinical Medicine recently concluded a study in which they suggest that a wide variety of construction workers face significant risks of suffering from mesothelioma – even if they didn’t work jobs known for higher rates of asbestos exposure. According to the Keep Reading
Mesothelioma

Popular Posts

Late last month – on Tuesday, October 21 st – Johnson & Johnson’s Janssen unit announced a recall of the popular blood-thinner medication Xarelto (rivaroxaban). According to officials from Janssen, 13,500 bottles of Xarelto are being recalled after microbial contamination was found in a sample. The U.S. Food and Drug Keep Reading
Pharmaceutical Injuries
In the past several months, concerns over the risks and safety of Xarelto – a popular prescription blood thinner – have been on the rise. In many cases, patients who took Xarelto have reported incidents of severe and uncontrollable bleeding, some serious enough to require hospitalization. A number of injuries Keep Reading
Pharmaceutical Injuries
A recent study conducted by a team of researchers at the University of Hawaii Cancer center is breaking new ground in the scientific understanding of mesothelioma. According to the researchers, mesothelioma may be caused by multiple cell mutations rather than a mutation in a single cell – which is the Keep Reading
Mesothelioma
Earlier this month, the U.S. Judicial Panel on Multidistrict Litigation announced the consolidation of federal Xarelto lawsuits in the United States District Court for the Eastern District of Louisiana. The announcement, made on December 12, is considered a turning point in nationwide litigation involving the popular blood-thinner, which has been Keep Reading
Pharmaceutical Injuries
Swedish researchers from Umea University’s Department of Health and Clinical Medicine recently concluded a study in which they suggest that a wide variety of construction workers face significant risks of suffering from mesothelioma – even if they didn’t work jobs known for higher rates of asbestos exposure. According to the Keep Reading
Mesothelioma

We fight for you.


Phone: 866.342.1929
Email: info@nemerofflaw.com